The Small Molecule Screening and Synthesis Facility (SMSSF) Shared Resource provides UW Carbone Cancer Center (UWCCC) members, other UW faculty and students, and scientists from other universities and companies with fee-for-service access to early stage drug discovery infrastructure, expert staff and services. These services include:
These activities foster collaborative drug discovery research between chemists, biologists and physician scientists that leads to the identification of new small molecules that inhibit cancer phenotypes in cellular or animal models and that can be further developed for clinical evaluation in human cancer patients. SMSSF services also are available for drug discovery in all other therapeutic areas.
Learn more about the Small Molecule Screening and Synthesis Facility's Scientific Accomplishments.
SMSSF is one of the sponsors of the Development of Robust Experimental Asay Methods (aDREAM) Conference 2013 on October 18, 2013.
Funding received from the UWCCC Cancer Center Support Grant (CCSG) for published research, including the use of UWCCC Shared Resources to generate or analyze data, or conduct clinical trials, needs to reference the UWCCC. See Acknowledging UWCCC in Publications, Posters and Presentations.
SMSSF Advisory Board
W. John Kao, PhD, FBSE
Laura L. Kiessling, PhD